The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

Cold weather means it’s time to check in about whether or not you should be getting certain vaccines. The CDC has shared new ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Everything you need to know about getting a Covid-19 vaccination ... there are vaccination updates in your state: The Plan Your Vaccine page will be updated as new information is released from ...

As the 130+ vaccine candidates currently in development progress through clinical testing, a key question for their manufacturers is how COVID-19 might ... $65 per vial (meaning a full course ...

Vaxxas’ proprietary high-density microarray patch (HD-MAP) technology is currently being evaluated in a phase 1 clinical study of the first needle-free COVID-19 vaccine, having demonstrated ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

MDV: Multidose vial; NA: Not available ... influenza vaccination campaign estimated that the total time to get a vaccine ready to be administered per patient was 87 s for MDVs and 49.71 s for ...

is supplied in a kit containing a vial of risperidone microsphere powder for suspension, a syringe containing diluent, a safety needle, a device for attaching the diluent syringe to the vial ...

Welcome to this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox.